Skip to content

More2C

Active
Private limited companyfounded 20214 years activeDurmstraat 76, 9930 Lievegem, BelgiumKBO/BCE: BE 0779.294.436
Summary

More2C has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €657,332 and a net result of €110,257. Its solvency ranks better than 73% of 9,663 sector peers (NACE 46, fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Overview

Activity
Wholesale of pharmaceutical and medical goods
NACE 46460Organisation of conventions and trade shows NACE 82300
1 site
Size
€965,840total assets 2025
Staff
2.3 FTE
Equity
€657,332
Profit
€110,257
Turnover not published (abridged schema)
Financial health
97 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.1%
Structure
  • Decorte CarineDirector
Accounts 12 days early1 of 2 deeds read
Why 97- Founded in 2021+ Liquidity: current ratio 3.18, cash €436,248+ Figures for FY 2025 (filed 19-07-2026)+ Equity €657,332 (68.1% of total assets)Show the evidence

Checked score

Score 2025
97 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 80% of its sector peers (NACE 46, micro)
Financial strength
Strong
Solvency 93
equity 68.1% of total assets
Liquidity 89
short-term debt 27.4% · cash 45.2%
Profitability 83
return on assets 11.4%
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.4% (26,860 companies)
Last 24 months 11-2024: 6.6% 12-2024: 6.6%● unchanged vs 11-2024 01-2025: 6.6%● unchanged vs 12-2024 02-2025: 6.6%● unchanged vs 01-2025 03-2025: 6.6%● unchanged vs 02-2025 04-2025: 6.6%● unchanged vs 03-2025highest value 05-2025: 6.6%● unchanged vs 04-2025highest value 06-2025: 6.6%● unchanged vs 05-2025highest value 07-2025: 6.6%● unchanged vs 06-2025highest value 08-2025: 6.6%● unchanged vs 07-2025highest value 09-2025: 5.8%▼ -0.8 percentage points vs 08-2025 10-2025: 5.8%● unchanged vs 09-2025 11-2025: 5.8%● unchanged vs 10-2025 12-2025: 5.6%▼ -0.2 percentage points vs 11-2025 01-2026: 5.5%▼ -0.1 percentage points vs 12-2025 02-2026: 5.5%● unchanged vs 01-2026 03-2026: 5.5%● unchanged vs 02-2026 04-2026: 5.5%● unchanged vs 03-2026 05-2026: 5.5%● unchanged vs 04-2026 06-2026: 5.6%▲ +0.1 percentage points vs 05-2026 07-2026: 5.6%● unchanged vs 06-2026 08-2026: 0.1%▼ -5.5 percentage points vs 07-2026lowest value 09-2026: 0.1%● unchanged vs 08-2026lowest value 10-2026: 0.1%● unchanged vs 09-2026lowest value
Credit up to €60,000 at 30 days acceptable
Liquidity ample (current ratio 3.18; short-term debt: 27.4% and cash: 45.2% of total assets), and 31.9% of the assets are financed with debt.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 46, micro): better than 73% on solvency, 88% on liquidity and 77% on profitability.

The bankruptcy probability was computed on 07-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Five signals.
−lowers risk+raises risk○neutral
lowers risk · Liquidity: current ratio 3.18, cash €436,248
NBB · annual accounts
raises risk · Founded in 2021
How long the company has existed counts in the probability; how much depends on the rest of its profile.
KBO
lowers risk · Figures for FY 2025 (filed 19-07-2026)
NBB · annual accounts
lowers risk · Equity €657,332 (68.1% of total assets)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 19-07-2026, 12 days ahead of the deadline.
NBB · 1 filing
Deviation from the deadline
2025
12 days early
← before the deadline after the deadline →
Checked, nothing found (1)
neutral · No strike-offs in the KBO publications
Checked from 2021 on.
KBO publications · our coverage
  1. Annual accounts filedfiscal year 2025 · abbreviated…
  2. Resignation: Decorte Carine (manager)Appointment: Decorte Carine (non-statutory director)…

Key points

  • New directorlatest change 13-10-2025 · 1 in office 1 joined View
  • Total assets 2025first fiscal year filed €965,840 View
  • Active since 2021founded 23-12-2021 4 years View

By topic

Financials

Fiscal year
2025
Total assets
€965,840
Profit
€110,257
Solvency
68.1%
Go to Financials

Company details

Sites
1
Legal form
Private limited company
Activity
Wholesale of pharmaceutical and medical goodsNACE 46460
Founded
23-12-2021
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Articles of association

Provisions read
21
Who signs
Each director alone
Annual meeting
Second Tuesday of June at 11:00
Purpose
De aan- en verkoop, de groot- en kleinhandel, de import en export, agentuur…
Go to Articles of association

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.